212 related articles for article (PubMed ID: 38329437)
1. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer.
Liu J; Miao X; Yao J; Wan Z; Yang X; Tian W
Aging (Albany NY); 2024 Feb; 16(3):2934-2952. PubMed ID: 38329437
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
[TBL] [Abstract][Full Text] [Related]
3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
[TBL] [Abstract][Full Text] [Related]
6. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
7. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
8. Expression of pyroptosis-associated genes and construction of prognostic model for thyroid cancer.
Guo L; Yuan M; Jiang S; Jin G; Li P
Transl Cancer Res; 2023 Dec; 12(12):3360-3383. PubMed ID: 38193001
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
[TBL] [Abstract][Full Text] [Related]
11. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38836761
[TBL] [Abstract][Full Text] [Related]
12. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
13. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
Fei H; Han X; Wang Y; Li S
Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
[TBL] [Abstract][Full Text] [Related]
14. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy.
Cui Z; Liu C; Li H; Wang J; Li G
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454
[TBL] [Abstract][Full Text] [Related]
15. Identifying and Validating an Angiogenesis-related Signature for the Prognosis of Head and Neck Squamous Cell Carcinoma.
Hou Y; Pang H; Xu X; Zhao D
Curr Med Chem; 2024 May; ():. PubMed ID: 38752633
[TBL] [Abstract][Full Text] [Related]
16. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
17. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
18. Construction and Evaluation of a Tumor Mutation Burden-Related Prognostic Signature for Thyroid Carcinoma.
Lu H; Liu Q; Chang Q; Du J; Zhang C; Chang W; Guo X; Hu Y; Liu S; Tang G; Chen C
Comput Math Methods Med; 2021; 2021():1435827. PubMed ID: 34697553
[TBL] [Abstract][Full Text] [Related]
19. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
20. Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy.
Xia M; Wang S; Ye Y; Tu Y; Huang T; Gao L
Front Immunol; 2022; 13():995645. PubMed ID: 36389678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
